Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

NLRP3/NALP3 (human) monoclonal antibody (Nalpy3-b)

 
ALX-804-819-C100 100 µg 412.00 USD
Do you need bulk/larger quantities?
 

Product Details

Alternative Name:NACHT-, LRR- and PYD-containing protein 3, CIAS1, Cryopyrin, Cold autoinflammatory syndrome 1 protein, PYPAF1, PYRIN-containing APAF1-like protein 1
 
Clone:Nalpy3-b
 
Host:Mouse
 
Isotype:IgG1
 
Immunogen:Recombinant human NLRP3/NALP3 (NACHT-, LRR- and PYD-containing protein 3) (pyrin domain).
 
UniProt ID:Q96P20
 
Source:Purified from concentrated hybridoma tissue culture supernatant.
 
Species reactivity:Human
 
Specificity:Detects endogenous protein by IP and WB.
 
Applications:IHC (FS), IP, WB
 
Recommended Dilutions/Conditions:Immunoprecipitation (1:50)
Western Blot (1:1,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Formulation:Liquid. In PBS containing 0.02% sodium azide.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Blue Ice
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
Regulatory Status:RUO - Research Use Only
 
NLRP3/NALP3 (human) monoclonal antibody (Nalpy3-b) Immunohistochemistry
Figure: Staining of endogenous NLRP3/NALP3 in epithelial layer of human tonsil (frozen section) using NLRP3/NALP3 (human), mAb (Nalpy3-b) (Prod. No. ALX-804-819). Method: 5µm thick frozen section of tissue are dried and fixed with acetone. Tissue is washed with PBS and incubated with NLRP3/NALP3 (human), mAb (Nalpy3-b). Picture courtesy of Dr. Alain Kummer, University Medical Center Utrecht, The Netherlands."
Please mouse over
NLRP3/NALP3 (human) monoclonal antibody (Nalpy3-b) Immunohistochemistry

Product Literature References

Canagliflozin inhibits inflammasome activation in diabetic endothelial cells - Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells: X. Li, et al.; Biomed. Pharmacother. 159, 114228 (2023), Abstract;
Inflammasome assembly is required for intracellular formation of β2-microglobulin amyloid fibrils, leading to IL-1β secretion: N. Kaneko, et al.; Int. J. Immunopathol. Pharmacol. 36, 3946320221104554 (2022), Abstract;
ASC and NLRP3 maintain innate immune homeostasis in the airway through an inflammasome-independent mechanism: R. Fang, et al.; Mucosal Immunol. 12, 1092 (2019), Abstract;
Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration: C. Kosmidou, et al.; Sci. Rep. 8, 61 (2018), Abstract; Full Text
Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states: D. Furman, et al.; Nat. Med. 23, 174 (2017), Abstract; Full Text
Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation: J. Cosin-Roger, et al.; Nat. Commun. 8, 98 (2017), Abstract; Full Text
PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner: M.R. Spalinger, et al.; Autophagy 13, 1590 (2017), Abstract; Full Text
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease: Q. Zhou, et al.; Nat. Genet. 48, 67 (2016), Application(s): Immunoblots of total cell lysates, Abstract;
Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages: Y.W. An, et al.; Neurobiol. Aging 38, 1 (2016), Application(s): Western blot, Abstract;
Dysregulated production of interleukin-1β upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever: A. Repa, et al.; Hum. Immunol. 76, 488 (2015), Application(s): Western Blot, Abstract;
Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis: C. Choulaki, et al.; Arthritis Res. Ther. 17, 257 (2015), Abstract; Full Text
Mechanism of hepatic inflammation during hepatitis C virus infection: A.A. Negash, et al.; (2013), (Thesis paper), Application(s): WB, IHC of human liver cells, Abstract;
NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration: W.A. Tseng, et al.; Invest. Ophthalmol. Vis. Sci. 54, 110 (2013), Application(s): Immunohistochemistry of paraffin-embedded tissue, Abstract; Full Text
Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and Rat Conjunctival Goblet Cells: V. McGilligan, et al.; PLoS One 8, e74010 (2013), Application(s): WB, IHC, and Cell culture of rat and human cells, Abstract; Full Text
Complement Protein C1q Directs Macrophage Polarization and Limits Inflammasome Activity during the Uptake of Apoptotic cells: M. Benoit, et al.; J. Immunol. 188, 5682 (2012), Application(s): WB, Cell culture of human lymphocytes and macrophages, Abstract; Full Text
Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases: M.T. Shio, et al.; PLoS Pathog. 5, e1000559 (2009), Abstract;
Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome: A. Lev-Sagie, et al.; Am. J. Obstet. Gynecol. 200, 303 (2009), Application(s): Immunohistochemistry of paraffin-embedded tissue, Abstract;
Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response: J.A. Kummer, et al.; J. Histochem. Cytochem. 55, 443 (2007), Abstract;
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder: L. Agostini, et al.; Immunity 20, 319 (2004), Abstract;

General Literature References

Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases: F. Martinon and J. Tschopp; Cell 117, 561 (2004), Abstract;
Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties: W. O'Connor, Jr., et al.; J. Immunol. 171, 6329 (2003), Abstract;
Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation: M. Chamaillard, et al.; Cell. Microbiol. 5, 581 (2003), Abstract; Full Text

Product Toolbox

PRODUCT RESOURCES

Datasheet
SDS
Certificate of Analysis

RELATED PRODUCTS

By target:
NALP
By biological activity:
NALP Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service